← All companies
NOVAVAX INC
NVAX - Company ID 0001000694
Market cap$1.54 B
Rank#2341
Filings1,627
The table below shows NOVAVAX INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $240.63M | $530.23M | $568.50M | $1.34B | $1.52B | $553.40M |
| Short-term investments | $494.45M | $392.89M | - | - | $0.00 | $157.65M |
| Receivables | - | - | - | - | - | - |
| Inventory | $11.54M | $8.75M | $41.70M | $36.68M | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.